Drug Trial Radar · NCT07648225
UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Sep 4, 2026
Primary completion
Sep 29, 2027
Study completion Nov 3, 2027
Sponsor
- Lead sponsor
- The United Bio-Technology (Hengqin) Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 15, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized, double-blind, parallel, placebo-controlled phase Ⅲ study to evaluate the efficacy and safety of UBT251 Injection in overweight/obese patients
Conditions
- Obesity & Overweight
Interventions
UBT251 Injection 4.0 mgDrug
UBT251 Injection subcutaneously once weekly
UBT251 Injection 6.0 mgDrug
UBT251 Injection and UBT251 Injection Placebo subcutaneously once weekly
UBT251 Injection Placebo 4.0 mgDrug
UBT251 Injection placebo subcutaneously once weekly
UBT251 Injection Placebo 6.0 mgDrug
UBT251 Injection placebo subcutaneously once weekly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Body WeightTime frame: Week 52
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Peking University People's Hospital
Beijing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.